NCT02194777View on ClinicalTrials.gov

Safety, Tolerability and Pharmacokinetics of Inhalative Administration of BIBN 4096 BS in Healthy Male and Female Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

June 30, 2001

Primary Completion Date

August 31, 2001

Conditions
Healthy
Interventions
DRUG

BIBN 4096 BS - in single rising doses

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY